An In-Depth Financial Performance Analysis and Cash Management Strategy of Solara Active Pharma Sciences Limited: A Case Study (2020-2023)

This study presents an in-depth financial analysis of Solara Active Pharma Sciences Limited (SAPS) over the period from 2020 to 2023, with a focus on the company’s financial performance and cash management strategies. The research primarily employs ratio analysis to evaluate profitability, liquidity, and operational efficiency. Additionally, the study applies the Baumol Model for optimal cash management, addressing the firm’s cash conversion cycle, opportunity costs, and transaction costs. The results reveal critical insights into SAPS’s fiscal health, suggesting that while the company demonstrates robust profitability, it can further optimize its liquidity management. Recommendations include revising cash management practices and employing more effective marketable securities strategies to enhance liquidity.